The 13th Annual Koch Institute Summer Symposium, “RNA Biology, Cancer and Therapeutic Implications,” will be held on Friday, June 13, 2014 at Kresge Auditorium at the MIT campus in Cambridge, Massachusetts. The symposium will help unravel the molecular and cellular mechanisms underlying RNA-based gene regulation in humans and provide updates on the latest breakthroughs and challenges in the development of RNA-based prognostic tools and therapies for cancer.
Registration is not yet open.
Phillip Sharp, PhD
Sangeeta Bhatia, MD, PhD
Phillip Sharp, PhD, Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology - Opening Remarks
Joshua Mendell, MD, PhD, UT Southwestern
Laurie Boyer, PhD, Massachusetts Institute of Technology
Daniel Anderson, PhD, Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology
John Maraganore, PhD, Alnylam Pharmaceuticals
David Bartel, PhD, Whitehead Institute and Massachusetts Institute of Technology
Stan Crooke, MD, PhD, Isis Pharmaceuticals, Inc.
Jeannie Lee, MD, PhD, Massachusetts General Hospital
Jennifer Doudna, PhD, University of California, Berkley
Scott Lowe, PhD, Memorial Sloan-Kettering Cancer Center
Sangeeta Bhatia, MD, PhD, Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology
Janssen R&D LLC
Merrimack Pharmaceuticals, Inc.
Mirrx Therapeutics A/S
Moderna Therapeutics, Inc.
RaNA Therapeutics Inc.
This activity is supported by an educational donation provided by Amgen.